270 related articles for article (PubMed ID: 18588325)
21. Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer.
Orchekowski R; Hamelinck D; Li L; Gliwa E; vanBrocklin M; Marrero JA; Vande Woude GF; Feng Z; Brand R; Haab BB
Cancer Res; 2005 Dec; 65(23):11193-202. PubMed ID: 16322270
[TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis of human blood serum using peptide library beads.
Sennels L; Salek M; Lomas L; Boschetti E; Righetti PG; Rappsilber J
J Proteome Res; 2007 Oct; 6(10):4055-62. PubMed ID: 17877382
[TBL] [Abstract][Full Text] [Related]
23. Avoiding nonspecific interactions in studies of the plasma proteome: practical solutions to prevention of nonspecific interactions for label-free detection of low-abundance plasma proteins.
Richens JL; Lunt EA; Sanger D; McKenzie G; O'Shea P
J Proteome Res; 2009 Nov; 8(11):5103-10. PubMed ID: 19817376
[TBL] [Abstract][Full Text] [Related]
24. Systematic antibody and antigen-based proteomic profiling with microarrays.
Ayoglu B; Häggmark A; Neiman M; Igel U; Uhlén M; Schwenk JM; Nilsson P
Expert Rev Mol Diagn; 2011 Mar; 11(2):219-34. PubMed ID: 21405972
[TBL] [Abstract][Full Text] [Related]
25. Challenges facing the development and use of protein chips to analyze the phosphoproteome.
Beernink HT; Nock S
Expert Rev Proteomics; 2005 Aug; 2(4):487-97. PubMed ID: 16097883
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of antibodies and microarray coatings as a prerequisite for the generation of optimized antibody microarrays.
Angenendt P; Glökler J
Methods Mol Biol; 2004; 264():123-34. PubMed ID: 15020785
[TBL] [Abstract][Full Text] [Related]
27. Design of atto-vial based recombinant antibody arrays combined with a planar wave-guide detection system.
Ghatnekar-Nilsson S; Dexlin L; Wingren C; Montelius L; Borrebaeck CAK
Proteomics; 2007 Feb; 7(4):540-547. PubMed ID: 17309099
[TBL] [Abstract][Full Text] [Related]
28. Quality control for a large-scale study using protein arrays and protein beads to measure immune response in serum and plasma.
Ghevaria N; Visser M; Hoffmann R
Proteomics; 2012 Sep; 12(18):2802-7. PubMed ID: 22887980
[TBL] [Abstract][Full Text] [Related]
29. Quantification of target proteins using hydrogel antibody arrays and MALDI time-of-flight mass spectrometry (A2M2S).
Darii E; Lebeau D; Papin N; Rubina AY; Stomakhin A; Tost J; Sauer S; Savvateeva E; Dementieva E; Zasedatelev A; Makarov AA; Gut IG
N Biotechnol; 2009 Sep; 25(6):404-16. PubMed ID: 19552888
[TBL] [Abstract][Full Text] [Related]
30. Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling.
Nilsson P; Paavilainen L; Larsson K; Odling J; Sundberg M; Andersson AC; Kampf C; Persson A; Al-Khalili Szigyarto C; Ottosson J; Björling E; Hober S; Wernérus H; Wester K; Pontén F; Uhlen M
Proteomics; 2005 Nov; 5(17):4327-37. PubMed ID: 16237735
[TBL] [Abstract][Full Text] [Related]
31. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.
Gnjatic S; Wheeler C; Ebner M; Ritter E; Murray A; Altorki NK; Ferrara CA; Hepburne-Scott H; Joyce S; Koopman J; McAndrew MB; Workman N; Ritter G; Fallon R; Old LJ
J Immunol Methods; 2009 Feb; 341(1-2):50-8. PubMed ID: 19041653
[TBL] [Abstract][Full Text] [Related]
32. Progress in miniaturization of protein arrays--a step closer to high-density nanoarrays.
Wingren C; Borrebaeck CA
Drug Discov Today; 2007 Oct; 12(19-20):813-9. PubMed ID: 17933681
[TBL] [Abstract][Full Text] [Related]
33. Multiplexed PrEST immunization for high-throughput affinity proteomics.
Larsson K; Wester K; Nilsson P; Uhlén M; Hober S; Wernérus H
J Immunol Methods; 2006 Aug; 315(1-2):110-20. PubMed ID: 16949094
[TBL] [Abstract][Full Text] [Related]
34. Antibody array analysis of labelled proteomes: how should we control specificity?
Holm A; Wu W; Lund-Johansen F
N Biotechnol; 2012 Jun; 29(5):578-85. PubMed ID: 21840428
[TBL] [Abstract][Full Text] [Related]
35. Magnetic bead-based detection of autoimmune responses using protein microarrays.
Gantelius J; Hartmann M; Schwenk JM; Roeraade J; Andersson-Svahn H; Joos TO
N Biotechnol; 2009 Dec; 26(6):269-76. PubMed ID: 19664732
[TBL] [Abstract][Full Text] [Related]
36. Protein microarray technology for unraveling the antibody specificity repertoire against microbial proteomes.
Bacarese-Hamilton T; Gray J; Crisanti A
Curr Opin Mol Ther; 2003 Jun; 5(3):278-84. PubMed ID: 12870438
[TBL] [Abstract][Full Text] [Related]
37. A cancer protein microarray platform using antibody fragments and its clinical applications.
Song S; Li B; Wang L; Wu H; Hu J; Li M; Fan C
Mol Biosyst; 2007 Feb; 3(2):151-8. PubMed ID: 17245494
[TBL] [Abstract][Full Text] [Related]
38. Technical report: xMAPr - High-dynamic-range (HDR) quantification of antigen-specific antibody binding.
Meyer TC; Schmidt F; Steinke J; Bröker BM; Völker U; Michalik S
J Proteomics; 2020 Feb; 212():103577. PubMed ID: 31683064
[TBL] [Abstract][Full Text] [Related]
39. Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements.
Zhou H; Bouwman K; Schotanus M; Verweij C; Marrero JA; Dillon D; Costa J; Lizardi P; Haab BB
Genome Biol; 2004; 5(4):R28. PubMed ID: 15059261
[TBL] [Abstract][Full Text] [Related]
40. Comparative protein profiling of serum and plasma using an antibody suspension bead array approach.
Schwenk JM; Igel U; Kato BS; Nicholson G; Karpe F; Uhlén M; Nilsson P
Proteomics; 2010 Feb; 10(3):532-40. PubMed ID: 19953555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
